Find a Doctor

Giuseppe C. Ippolito

National Institute For Infectious Diseases Lazzaro Spallanzani
Male

Bio


Giuseppe Ippolito is in Rome, Italy. He has been an author on 394 peer reviewed articles in the past 15 years.

Contact

Rome, IT

Latest Advances


Latest Advance
Study
  • Condition: Chronic Hepatitis C and Severe Liver Fibrosis
  • Journal: The new microbiologica
  • Treatment Used: Direct Antiviral Agents (DAAs)
  • Number of Patients: 205
  • Published —
This study evaluated measures of glycemia in patients with chronic hepatitis C (CHC)-related liver diseases treated with direct antiviral agents (DAA).
Latest Advance
Study
  • Condition: Ebola Virus Disease (EVD) in Guinea
  • Journal: The Journal of infectious diseases
  • Treatment Used: Favipiravir
  • Number of Patients: 286
  • Published —
This study assessed associations between potential risk factors, alterations in blood chemistry findings, favipiravir treatment, and outcome in patients with ebola virus disease in Guinea.
Latest Advance
Study
  • Condition: Patients with Ebola Virus Disease (EVD) in West Africa
  • Journal: Intensive care medicine
  • Treatment Used: Intensive Care Support
  • Number of Patients: 229
  • Published —
This study investigated the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD) in West Africa.
Latest Advance
Study
  • Condition: Chronic Hepatitis C (CHC)
  • Journal: BMC infectious diseases
  • Treatment Used: Second Generation Direct Acting Antivirals (DAAs)
  • Number of Patients: 5279
  • Published —
This study presented the results of the first analysis carried out on data of Lazio clinical network for direct acting antivirals (DAAs).

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Circulation. Heart failure
  • Published —
Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series.

Contact

Rome, IT

Insurance

Contact them to find out if they accept your insurance plan.